Quotient Wealth Partners LLC raised its holdings in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 4.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 2,615 shares of the financial services provider’s stock after buying an additional 108 shares during the period. Quotient Wealth Partners LLC’s holdings in Aflac were worth $270,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of AFL. Empowered Funds LLC increased its position in shares of Aflac by 10.0% during the fourth quarter. Empowered Funds LLC now owns 38,039 shares of the financial services provider’s stock worth $3,935,000 after acquiring an additional 3,454 shares in the last quarter. Advisory Resource Group increased its holdings in Aflac by 7.2% during the 4th quarter. Advisory Resource Group now owns 45,754 shares of the financial services provider’s stock worth $4,733,000 after purchasing an additional 3,056 shares in the last quarter. Kingsview Wealth Management LLC raised its stake in shares of Aflac by 146.2% in the fourth quarter. Kingsview Wealth Management LLC now owns 33,018 shares of the financial services provider’s stock worth $3,415,000 after purchasing an additional 19,608 shares during the last quarter. Apollon Wealth Management LLC lifted its holdings in shares of Aflac by 13.1% in the fourth quarter. Apollon Wealth Management LLC now owns 34,907 shares of the financial services provider’s stock valued at $3,611,000 after purchasing an additional 4,048 shares in the last quarter. Finally, Vest Financial LLC boosted its position in shares of Aflac by 7.1% during the fourth quarter. Vest Financial LLC now owns 826,348 shares of the financial services provider’s stock valued at $85,477,000 after buying an additional 54,973 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.
Aflac Trading Up 0.5 %
Shares of Aflac stock opened at $103.62 on Monday. The stock has a market capitalization of $57.56 billion, a P/E ratio of 10.79, a P/E/G ratio of 2.10 and a beta of 0.99. Aflac Incorporated has a 52-week low of $77.01 and a 52-week high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock’s 50-day simple moving average is $104.66 and its 200 day simple moving average is $106.87.
Aflac Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be given a $0.58 dividend. The ex-dividend date is Wednesday, February 19th. This is a boost from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 annualized dividend and a dividend yield of 2.24%. Aflac’s payout ratio is 20.83%.
Insider Activity at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.90% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of equities research analysts recently commented on AFL shares. Truist Financial increased their price target on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Piper Sandler lowered their target price on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday. BMO Capital Markets assumed coverage on shares of Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price target on the stock. Keefe, Bruyette & Woods decreased their price objective on shares of Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a research note on Friday, January 10th. Finally, Barclays cut their target price on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus price target of $103.21.
View Our Latest Research Report on Aflac
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Volatility ETFs to Help You Profit from Market Chaos
- Consumer Staples Stocks, Explained
- Lam Research: Is a NAND Upgrade Cycle the Next Growth Catalyst?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.